Study on association between genetic polymorphisms of haem oxygenase-1, tumour necrosis factor, cadmium exposure and malaria pathogenicity and severity
Open Access
- 17 September 2010
- journal article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 9 (1), 260
- https://doi.org/10.1186/1475-2875-9-260
Abstract
Background: Malaria is the most important public health problems in tropical and sub-tropical countries. Haem oxygenase (HO) enzyme and the pro-inflammatory cytokine tumour necrosis factor (TNF) have been proposed as one of the factors that may play significant role in pathogenicity/severity of malaria infection. HO is the enzyme of the microsomal haem degradation pathway that yields biliverdin, carbon monoxide, and iron. In this study, the association between malaria disease pathogenicity/severity and (GT)n repeat polymorphism in the promoter region of the inducible HO-1 including the effect of cadmium exposure (potent inducer of HO-1 transcription) as well as polymorphism of TNF were investigated. Methods: Blood samples were collected from 329 cases non-severe malaria with acute uncomplicated Plasmodium falciparum malaria (UM) and 80 cases with Plasmodium vivax malaria (VM), and 77 cases with severe or cerebral malaria (SM) for analysis of genetic polymorphisms of HO-1 and TNF and cadmium levels. These patients consisted of 123 (25.3%) Thai, 243 (50.0%) Burmese and 120 (24.7%) Karen who were present at Mae Sot General Hospital, Mae Sot, Tak Province, Thailand. Results: The number of (GT)n repeats of the HO-1 gene in all patients varied between 16 and 39 and categorized to short (S), medium (M) and long (L) GTn repeats. The genotype of (GT)n repeat of HO-1 was found to be significantly different among the three ethnic groups of patients. Significantly higher frequency of S/L genotype was found in Burmese compared with Thai patients, while significantly lower frequencies of S/S and M/L but higher frequency of M/M genotype was observed in Burmese compared with Karen patients. No significant association between HO-1 and TNF polymorphisms including the inducing effect of cadmium and malaria pathogenicity/severity was observed. Conclusions: Difference in the expression of HO-1 genotype in different ethnic groups may contribute to different severity of malaria disease. With this limited sample size, the finding of the lack of association between malaria disease pathogenicity/severity genetic polymorphisms of HO-1 (GT)n repeat as well as TNF observed in this study may not entirely exclude their possible link with malaria disease pathogenicity/severity. Further study in larger sample size is required.Keywords
This publication has 47 references indexed in Scilit:
- Possible Role of Heme Oxygenase-1 and Prostaglandins in the Pathogenesis of Cerebral Malaria: Heme Oxygenase-1 Induction by Prostaglandin D2 and Metabolite by a Human Astrocyte Cell LineThe Korean Journal of Parasitology, 2010
- Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cellsBiochemical and Biophysical Research Communications, 2008
- Monitoring of cadmium toxicity in a Thai population with high-level environmental exposureToxicology Letters, 2007
- Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patientsHuman Genetics, 2002
- Plasma Interleukin?10:Tumor Necrosis Factor (TNF)–? Ratio Is Associated with TNF Promoter Variants and Predicts Malarial ComplicationsThe Journal of Infectious Diseases, 2000
- Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Associated with Susceptibility to EmphysemaAmerican Journal of Human Genetics, 2000
- Severe Malarial Anemia and Cerebral Malaria Are Associated with Different Tumor Necrosis Factor Promoter AllelesThe Journal of Infectious Diseases, 1999
- Polymorphism of the 5′‐flanking region of the human tumor necrosis factor (TNF)‐α gene in JapaneseTissue Antigens, 1998
- Differential Control of the Metal-Mediated Activation of the Human Heme Oxygenase-1 and Metallothionein IIa GenesBiochemical and Biophysical Research Communications, 1995
- Clinical application of mefloquine pharmacokinetics in the treatment ofP falciparummalariaFundamental & Clinical Pharmacology, 1994